1 (Image 01)
Microgestin Fe 1.5/30 Kit
Product Images NDC 51862-870
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Microgestin Fe 1.5/30 (NDC 51862-870). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Mayne Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
2 (Image 02)
This is a table showing the lowest expected and typical failure rates of various birth control methods during the first year of continuous use. The failure rates are expressed as percentages of women who experience accidental pregnancy while using each method consistently and correctly during the first year if they do not stop for any other reason. The table covers several types of contraceptives, including oral contraceptives, diaphragms, spermicides, condoms, and sterilization for both men and women. The table makes no mention of non-English characters.*
3 (Image 03)
Cigarette smoking and oral contraceptive use can pose a serious risk to cardiovascular health, especially in older women and heavy smokers (15 or more cigarettes daily). Women who take oral contraceptives are advised to avoid smoking altogether.*
4 (Image 04)
5 (Image 05)
This text describes the mortality rate associated with different methods of fertility control among non-sterile women, according to age, as a measure of the number of birth-related or method-related deaths per 100,000 women. The table shows the risk associated with various methods, including no method, oral contraceptives for smokers and non-smokers, IUDs, condoms, diaphragms/spermicides, and periodic abstinence, for women ages 15-19 to 40-44, with deaths classified as either birth-related or method-related. The information is adapted from H.W. Ory's reference 41.*
6 (Image 06)
Cigarette smoking and oral contraceptive use can lead to serious cardiovascular side effects. Smoking, especially heavy smoking of 15 or more cigarettes per day, increases this risk, which is most notable in women over 35 years of age. Women who take oral contraceptives are strongly recommended not to smoke.*
7 (Image 07)
Microgestin Fe 1.5/30 is an oral contraceptive pill which comes in a package containing 21 yellow pills for week 1,2 and 3 and brown pills only for week 4. There's a guide showing the days of the week from left to right to help start the medication correctly.*
8 (Image 08)
Cigarette smoking and oral contraceptive use can lead to serious cardiovascular side effects. Heavy smoking and age over 35 can increase this risk significantly. It is strongly recommended that women using oral contraceptives should not smoke.*
9 (Image 09)
Cigarette smoking increases the risk of serious cardiovascular side effects from oral contraceptive use. This risk increases with age and with heavy smoking (15 or more cigarettes per day) and is quite marked in women over 35 years of age. Women who use oral contraceptives are strongly advised not to smoke.*
10 (Image 10)
11 (Image 11)
Microgestin Fe 1.5/30 is a type of birth control pill that comes in a pack of 28 pills. There are 21 yellow pills for weeks 1, 2, and 3 and 7 brown pills for week 4. The pills should be taken in the direction indicated on the pack, from left to right, each week. The text also includes a dosage schedule, but it is not clear due to errors.*
12 (Image 12)
13 (Image 13)
Microgestin® Fe 1.5/30 is a combination medication composed of Norethindrone Acetate and Ethinyl Estradiol, both are USP (United States Pharmacopeia) approved tablets, with Ferrous Fumarate Tablets. This medication is not available in a readable format due to errors.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
